# EGH Acquisition Corp. (EGHAR)

> Source: Nexqual · https://nexqual.com/EGHAR · data as of 2026-10-14 20:00 UTC · cite as "Nexqual, EGH Acquisition Corp. (EGHAR), nexqual.com/EGHAR" · informational, not investment advice.

**Price:** USD 0.25 (+0.00% on the day) · last close of Oct 14, 2026; US market closed, not a live price. Prev close 0.25 · day 0.19–0.26 · 52w 0.19–0.26 · market cap null · NGM

## Key facts
- Analysts: None.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2025 | TTM |
|---|---|---|
| Operating income | -$653K | -$2.0M |
| Net income | $3.4M | $3.7M |
| Cash + short-term investments | $778K | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)


## Analysts
Consensus None.

## Peers
DMAAR (Drugs Made In America Acquisiti) USD 0.12 -0.08% · AXINR (Axiom Intelligence Acquisition ) USD 0.13 -22.60% · EGHA (EGH Acquisition Corp.) USD 10.41 -0.19% · DAAQW (Digital Asset Acquisition Corp.) USD 0.15 -17.13% · HCACR (Hall Chadwick Acquisition Corp.) USD 0.21 +1.57%

## More
Full page: https://nexqual.com/EGHAR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt